Interaction between bile salts and beta-adrenoceptor antagonists

Area of Science:

• Pharmacology
• Physical Chemistry
• Biochemistry

Background:

• Bile salts are crucial for drug absorption.
• Beta-adrenoceptor antagonists (beta-blockers) are widely used medications.
• Understanding drug-bile salt interactions is vital for predicting in-vivo drug behavior.

Purpose of the Study:

• To investigate the interactions between specific beta-adrenoceptor antagonists and bile salts.
• To elucidate the thermodynamic and structural basis of these interactions.
• To assess the implications for in-vivo drug absorption.

Main Methods:

• Microcalorimetry was employed to study drug-bile salt interactions.
• Thermodynamic parameters were analyzed to characterize binding.
• Different concentrations and types of bile salts and beta-blockers were tested.

Main Results:

• Nadolol and oxprenolol exhibited 1:1 interactions with dihydroxy bile salts, indicating incorporation into bile salt aggregates.
• These interactions were primarily hydrophobic with a contribution from electrostatic forces.
• Atenolol and metoprolol did not interact with dihydroxy bile salts.
• Propranolol and alprenolol induced phase separation in dihydroxy bile salt solutions at higher concentrations.
• No interactions were observed with trihydroxy bile salts or at sub-aggregation concentrations.

Conclusions:

• Specific beta-blockers can interact with bile salts, affecting their aggregation and potentially influencing drug absorption.
• The nature of the interaction (hydrophobic/electrostatic) depends on the specific drug and bile salt structure.
• These findings highlight the importance of considering bile salt interactions in drug formulation and predicting pharmacokinetic behavior.